Scientists with the International VitGene Consortium project spanning 18 countries are working to understand the biology of vitiligo so that more effective vitiligo treatments can be designed.
Thanks to your involvement, the first two phases of this research project have been extraordinarily successful, discovering many vitiligo genes, resulting in real breakthroughs in understanding and opening doors to potential new treatments.
The U.S. National Institutes of Health (NIH) has now awarded a large research grant for a third phase of these studies, to discover additional vitiligo genes, deepen understanding, and provide even more new targets for vitiligo treatment. To accomplish this, they need to enroll 3000 additional Caucasian (white) vitiligo patients over the next two years. Participants must be from the USA or Canada and not have previously taken part.
Your participation is vitally needed. Please complete the questionnaire below and then email directly to Dr. Richard Spritz at the University of Colorado School of Medicine using the email address provided at the end of the questionnaire.
Your personal information, by law,
will be kept private and will not be sold or disclosed.
Join with us to work for a vitiligo-free future!
Click here to download the questionnaire
Click Here to Read Research Updates on this Study